FindTrial
Sign In

The value of strain elastography in evaluating ovarian reserve function

The value of strain elastography in evaluating ovarian reserve function

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500105223
Enrollment
Unknown
Registered
2025-07-01
Start date
2024-08-05
Completion date
Unknown
Last updated
2025-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Decreased ovarian reserve function

Interventions

Gold Standard:Anti-mullerian hormone
Index test:Strain elastography

Sponsors

Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1.Those who can tolerate transvaginal ultrasound examination; 2.DOR group AMH<1.1ng/ml; 3.The control group had an AMH of 1.1-4.6ng/ml.

Exclusion criteria

Exclusion criteria: 1.Age>45 years old; 2.Patients with polycystic ovary syndrome; 3.Patients with combined ovarian benign and malignant tumors; 4.Patients with combined thyroid or adrenal diseases; 5.Individuals who have recently undergone ovulation treatment or taken hormone medications.

Design outcomes

Primary

MeasureTime frame
Decreased ovarian reserve function;—

Countries

China

Contacts

Public ContactZeng Xinxin

Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region

854205476@qq.com+86 771 3916690

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026